LOGIN

Forgot password?
Sign up today and your first download is free.
REGISTER

Trans-Pacific Partnership

(Daily News)
October 19, 2011

The Obama administration has reworked a U.S. proposal for new rules to guide the behavior of state-owned enterprises (SOEs) and has circulated the updated text to its negotiating partners in the Trans-Pacific Partnership (TPP) trade talks, according to informed sources.


(Daily News)
October 19, 2011

With the ninth round of the Trans-Pacific Partnership (TPP) talks starting today (Oct. 19), 42 business groups sent a letter to President Obama urging him to negotiate a comprehensive deal that "provides full reciprocal market access and does not exclude any sector, sub-sector, product or service from the market-access provisions or core trade and investment rules."


(Daily News)
October 14, 2011

Deputy U.S. Trade Representative Demetrios Marantis said today (Oct. 14) that the United States expects to table its proposal for disciplining state-owned enterprises (SOEs) at next week's Trans-Pacific Partnership (TPP) negotiations in Peru but signaled it is unlikely to also table a labor proposal.


(Daily News)
October 06, 2011

Representatives of the U.S. brand-name drug industry this week said they are still unclear on exactly how the U.S. proposal on patent protections in the Trans-Pacific Partnership (TPP) talks would work, especially when it comes to the conditions under which they could benefit from relatively stronger patent protections, and the scope of those protections.


(Daily News)
October 05, 2011

Ways and Means Committee Ranking Member Sander Levin (D-MI) and Rep. Jim McDermott (D-WA), who is the ranking member on the trade subcommittee, today (Oct. 5) signaled their doubts about a new approach for patent protections that the Office of the U.S. Trade Representative is proposing in the Trans-Pacific Partnership (TPP) talks.


(Daily News)
September 12, 2011

The U.S. proposal on pharmaceutical patent provisions in the Trans-Pacific Partnership (TPP) talks moves away from the "May 10" deal on intellectual property rights (IPR) and appears to endorse a new approach under which pharmaceutical companies would be rewarded with stronger patent protections if they seek to gain marketing approval swiftly in other TPP countries.


(Text Document)
September 12, 2011

Pages